Remove 2016 Remove Drug Development Remove Life Science Remove Pharmaceuticals
article thumbnail

Medtech: BrainTale Gathers €4.5 Million to Accelerate the Development of Its Solution for Diagnosis, Monitoring and Prediction of Neurological Disorders

Digital Health Global

With this fundraising, BrainTale aims to provide physicians and pharmaceutical companies with innovative solutions to improve the diagnosis, monitoring and prediction of neurological diseases and disorders, in particular Alzheimer’s and Parkinson’s disease, amyotrophic lateral sclerosis and traumatic brain injury.

article thumbnail

Genomics Startup Human Longevity’s Valuation Falls 80% from $1.6 Billion down to $310M

Lloyd Price

and pharmaceutical entrepreneur Robert Duggan. Life-sciences companies recorded the strongest gains, Fenwick found, with their valuations rising 110% compared with their prior funding rounds. But key facets of its business didn’t develop as planned, say people familiar with the company.